Unique ID issued by UMIN | UMIN000027640 |
---|---|
Receipt number | R000031664 |
Scientific Title | A Prospective Clinical Trial of Carbon-ion Radiotherapy for Patients with Prostate Cancer of Clinical Stage T1c-T3N0M0 |
Date of disclosure of the study information | 2017/06/06 |
Last modified on | 2023/12/27 09:29:19 |
A Prospective Clinical Trial of Carbon-ion Radiotherapy for Patients with Prostate Cancer of Clinical Stage T1c-T3N0M0
Carbon-ion Radiotherapy for T1c-T3N0M0 Prostate Cancer (iROCK-1701PR)
A Prospective Clinical Trial of Carbon-ion Radiotherapy for Patients with Prostate Cancer of Clinical Stage T1c-T3N0M0
Carbon-ion Radiotherapy for T1c-T3N0M0 Prostate Cancer (iROCK-1701PR)
Japan |
Patients with Prostate Cancer of Clinical Stage T1c-T3N0M0
Radiology |
Malignancy
NO
To evaluate the safety and efficacy of the carbon ion radiotherapy for prostate cancer in Kanagawa Cancer Center
Safety,Efficacy
Confirmatory
Explanatory
Phase II
Biochemical progression-free survival at 5 years
1) Overall survival
2) Disease-specific survival
3) Event-free survival
4) Early and late-phase adverse event rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Carbon-ion radiation therapy
A total of 51.6Gy(RBE) consisting of 12 fractions; once a day 4.3 Gy(RBE), 6-8 times for 2 weeks
20 | years-old | <= |
Not applicable |
Male and Female
1) Histologically diagnosed primary prostate adenocarcinoma
2) Either clinical stage of T1c, T2a, T2b, T2c, T3a, or T3b and N0M0, in accordance with UICC 7th (2009)
3) ECOG Performance status is 0, 1 or 2
4) Twenty years old of age at registration or more
5) Untreated patient for prostate cancer, except for those who undergo neoadjuvant endocrine therapy
6) Patients are informed for diagnosis of prostate cancer and independently agree with this study on carbon-ion radiotherapy
1) Patient with past history of radiotherapy for the targeted lesion
2) Patient with castration-resistant prostate cancer
3) Patient with active double cancer
4) Patient with active and intractable infection in the targeted lesion.
5) Patient with metal devices in the lesion which will cause adverse risk by carbon-ion radiotherapy
6) Patient eligible for Advanced Medicine Program B (Sen-shin Iryo B)
7) Other medical or psychological condition which is unsuitable for carbon-ion therapy
689
1st name | Hiroyuki |
Middle name | |
Last name | Katoh |
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Department of Carbon-ion Radiotherapy
241-8515
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
hkatoh@kcch.jp
1st name | Hiroyuki |
Middle name | |
Last name | Katoh |
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Center for Carbon-ion Radiotherapy
241-8515
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
hkatoh@kcch.jp
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Self funding
Japan
None
None
Kanagawa Cancer Center IRB
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
clinical_trials@kcch.jp
NO
2017 | Year | 06 | Month | 06 | Day |
Unpublished
78
This study confirmed safety and efficacy comparable to those reported from prior facilities.
2023 | Year | 12 | Month | 27 | Day |
Completed
2017 | Year | 03 | Month | 09 | Day |
2017 | Year | 05 | Month | 18 | Day |
2017 | Year | 06 | Month | 13 | Day |
2028 | Year | 05 | Month | 31 | Day |
2028 | Year | 05 | Month | 31 | Day |
2028 | Year | 05 | Month | 31 | Day |
2029 | Year | 05 | Month | 31 | Day |
2017 | Year | 06 | Month | 05 | Day |
2023 | Year | 12 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031664